About the Authors
- Ulrike Baum
-
Contributed equally to this work with: Ulrike Baum, Eero Poukka
Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing
* E-mail: eero.poukka@thl.fi (EP); ulrike.baum@thl.fi (UB)
Affiliation Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
- Eero Poukka
-
Contributed equally to this work with: Ulrike Baum, Eero Poukka
Roles Formal analysis, Writing – original draft, Writing – review & editing
* E-mail: eero.poukka@thl.fi (EP); ulrike.baum@thl.fi (UB)
Affiliation Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
- Arto A. Palmu
-
Roles Conceptualization, Formal analysis, Writing – review & editing
Affiliation Population Health Unit, Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Tampere, Finland
- Heini Salo
-
Roles Formal analysis, Writing – review & editing
Affiliation Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
- Toni O. Lehtonen
-
Roles Data curation, Writing – review & editing
Affiliation Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
- Tuija Leino
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Supervision, Writing – review & editing
Affiliation Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
Competing Interests
The current study received no external funding outside THL. AAP is an investigator in studies (not related to the current study nor COVID-19) for which the Finnish Institute for Health and Welfare has received research funding from Sanofi Pasteur (influenza vaccine trial), GlaxoSmithKline (pneumococcal vaccine trial) and Pfizer (streptococcal study). There are no competing interests relating to employment, consultancy, patents, products in development, or marketed products. All other authors declare no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.